Placebo, chronic daily headache, and pain: Ten points to ponder

Current Pain and Headache Reports

Volumn 10, Issue 1, 2006, Pages 4-6

  Lake III, Alvin E ^a  

^a Pain and Neurological Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; DROPERIDOL; FENTANYL; KETOROLAC; MU OPIATE RECEPTOR; PETHIDINE; PLACEBO; SODIUM CHLORIDE; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; CHRONIC DAILY HEADACHE; CINGULATE GYRUS; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DRUG RESPONSE; HEADACHE; HUMAN; INSULA; MCGILL PAIN QUESTIONNAIRE; MIGRAINE; MORBIDITY; NOTE; NUCLEUS ACCUMBENS; PAIN; PREFRONTAL CORTEX; TENSION HEADACHE;

HEADACHE DISORDERS; HUMANS; PAIN; PLACEBO EFFECT; TREATMENT OUTCOME;

EID: 33645047419     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-006-0002-6     Document Type: Note

References (17)

1. Lake AE 3rd: Chronic daily headache in the absence of medication overuse: Is daily or continuous pain more treatment-resistant than chronic daily headache with pain-free days? Curr Pain Headache Rep 2005, 9:4-6.
2. van der Kuy PH, Lohman JJ: A quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002, 22:265-270.
3. Saper JR, Lake AE 3rd, Cantrell DT, et al.: Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002, 42:470-482.
4. Holroyd KA, O'Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208-2215.
5. Silberstein SD, Young WB, Mendizabal JE, et al.: Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology 2003, 60:315-321.
6. Jhee SS, Salazar DE, Ford NF, et al.: Monitoring of acute migraine attacks: placebo response and safety data. Headache 1998, 38:35-38.
7. Harden RN, Gracely RH, Carter T, Warner G: The placebo effect in acute headache management: ketorolac, meperidine, and saline in the emergency department. Headache 1996, 36:352-356.
8. Silberstein SD, Stark SR, Lucas SM, et al.: Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005, 80:1126-1137.
9. Levine JD, Gordon NC, Bornstein JC, Fields HL: Role of pain in placebo analgesia. Proc Natl Acad Sci U S A 1979, 76:3528-3531.
10. Pascual-Lozano AM, Chamarro-Lazaro R, Lainez MJ: Placebo response in a patient with chronic migraine and ergotic overuse. Cephalalgia 2005, 25:391-394.
11. Liberman R: An experimental study of the placebo response under three different situations of pain. J Psychiatr Res 1964, 33:233-246.
12. Evans FJ: The placebo response in pain reduction. In Advances in Neurology, vol 4. Edited by Bonica JJ. New York: Raven Press; 1974:289-296.
13. Vase L, Riley JL, Price DD: A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002, 99:443-452.
14. Zubieta JK, Bueller JA, Jackson LR, et al.: Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 2005, 25:7754-7762.
15. Barsky AJ, Saintfort R, Rogers MP, Borus JF: Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002, 287:622-627.
16. Moulin DE, Iezzi A, Amireh R, et al.: Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996, 347:143-147.
17. Price DD: Endogenous opioid and non-opioid pathways as mediators of placebo analgesia. In The Science of the Placebo Toward an Interdisciplinary Research Agenda. Edited by Guess HA, Kleinman A, Kusek JW, Engel LW. London: BMJ; 2002:183-206.